(Q41370879)

30 September 2017

Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer (English)

1 reference

30 September 2017

Ran Meng

1

1 reference

30 September 2017

Silvia D Chang

2

1 reference

30 September 2017

Edward C Jones

3

1 reference

30 September 2017

S Larry Goldenberg

4

1 reference

30 September 2017

Piotr Kozlowski

5

1 reference

30 September 2017

13 January 2010

1 reference

30 September 2017

1 reference

30 September 2017

17

1 reference

30 September 2017

4

1 reference

30 September 2017

520-525

1 reference

Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Key factors in the acquisition of contrast kinetic data for oncology

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Two-sided confidence intervals for the single proportion: comparison of seven methods

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891013

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA

19 August 2018

1 reference

12 December 2020

Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI

1 reference

12 December 2020

Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging

1 reference

12 December 2020

Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging

1 reference

12 December 2020

Quantitative Measurements of Prostatic Blood Flow and Blood Volume by Positron Emission Tomography

1 reference

12 December 2020

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

12 December 2020

Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model

1 reference

12 December 2020

Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results

1 reference

12 December 2020

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer

1 reference

12 December 2020

Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy

1 reference

12 December 2020

10.1016/J.ACRA.2009.11.006

Identifiers

DOI

1 reference

30 September 2017

1 reference

30 September 2017

1 reference